3 papers in the library · 3 citations · publishing 2023-2025
The American Journal of Bioethics 2025 Zachary J Verne, Natalie Gukasyan, Jeffrey S Zabinski 2 citations
In “Distinctive but not Exceptional: The Risks of Psychedelic Ethical Exceptionalism,” Cheung et al. (2025) elaborate the ways that psychedelics share individual ethical considerations with those o...
AMA journal of ethics November 1, 2024 Zachary J Verne, Jeffrey S Zabinski 1 citation
Psychedelics have long been used by individuals seeking peace and a sense of wellness. This article examines widespread adoption of ketamine as a proxy for psychedelics. For ketamine, there is a need to protect vulnerable persons from exploitation that should be balanced against risks of hypermedicalization. This article suggests strategies for striking such a balance, including by carefully...
Psychiatric News February 16, 2023 Jacques Ambrose, Jeffrey S Zabinski
With the impending FDA review of the phase 3 data for MDMA-assisted psychotherapy for PTSD, experts reflect on ethical considerations, appropriate use, and access. The groundswell of interest in psychedelics in psychiatry, medicine broadly, and in popular culture continues without a peak in sight. Though the term “psychedelic” was coined in the 20th century, these compounds have an extensive...